ebook Munafa Stock Market Course + Intraday & FNO calls  

       

AKER NEWS why is Akers Biosciences Inc. price falling or rising

AKER NEWS reasons for why stock price of Akers Biosciences Inc. is falling or rising

AKER Akers Biosciences is falling or rising technical reasons

Technical analysis forecast for Akers Biosciences Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Akers Biosciences AKER at this time. Stock is falling and might fall more.

It appears as if Akers Biosciences AKER gave a large move recently.

Stock of Akers Biosciences (AKER) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.

Although my analysis for Akers Biosciences is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 2.5, for a target of 2.8 or 3.1

AKER Akers Biosciences is falling or rising NEWS fundamental reasons

Indian drugmaker Sai Life Sciences to boost headcount by about 20% amid global demand upswing Sai Life Sciences will boost its workforce by over 700 employees next financial year. This expansion supports growing global demand for its services. The company is increasing capacity to meet this demand. New hires will focus on scientific, technical, and - NEWS as on 2026-02-20 indiatimes.com

French car parts maker Valeo unveils plans to increase sales in India Valeo India plans: Valeo said it would be investing more ?than 200 million euros (6.7 million) in the coming years to expand ?its presence in India ?and that ?these new investments were ?aimed ?at tripling Valeo's sales in ?India to around 700 million e - NEWS as on 2026-02-18 indiatimes.com

Mounjaro-maker Eli Lilly targets India as global export hub amid booming sales, executive says Eli Lilly aims to establish India as a key hub for its global supply chain. The company plans to export drugs manufactured locally in India to markets worldwide. This initiative is part of its significant investment in contract manufacturing within the cou - NEWS as on 2026-02-17 indiatimes.com

Drugmaker Sanofi to expand India GCC, increase workforce to over 4,500 employees French drugmaker Sanofi is set to significantly expand its global capability centre in Hyderabad. The company plans to more than double its workforce to over 4,500 employees. This expansion will be backed by a substantial multi-hundred-million investment. - NEWS as on 2026-02-16 indiatimes.com

US chipmaker KLA to invest ?3,600 cr in Tamil Nadu for global R&D campus, signs MoU with state government US-based semiconductor firm KLA has signed an MoU with the Tamil Nadu government to invest 0 million (about ?3,600 crore) to set up a global R&D and innovation campus in Chennai. - NEWS as on 2026-02-13 indiatimes.com

Contract drug maker Divi's misses profit view on high material costs The Hyderabad-based company's consolidated net profit marginally fell to ?583 crore (.31 million) in the quarter ended December 31, from ?589 crore a year earlier - NEWS as on 2026-02-11 business-standard.com

Reliance Consumer Products acquires health foods maker Southern Health Reliance Consumer Products has acquired Southern Health Foods of Tamil Nadu, owner of the Manna brand, to strengthen its foods and staples portfolio in the health foods segment - NEWS as on 2026-02-10 business-standard.com

GSTAT finds Wai Wai noodles maker guilty of GST profiteering The Goods and Services Tax Appellate Tribunal has ordered instant noodle maker CG Foods to deposit over ?90 lakh into the Consumer Welfare Fund. The tribunal found the company profiteered by not passing on a GST rate cut benefit to consumers. CG Foods incr - NEWS as on 2026-02-09 indiatimes.com

More announcements and NEWS

AKER Akers Biosciences Inc. current price & indicator signals

Moving Averages for Akers Biosciences Inc.

  • 5Day Average: 2.86
  • 12Day Average: 3.11
  • 20Day Average: 3.18
  • 50Day Average: 3.32
  • 100Day Average: 2.79
  • 150Day Average: 2.57
  • 200Day Average: 3.03

AKER Indicators & signals

Indicator MACD (12,26,9)

3, 3.14, -0.04
Indicator MACD is in negative zone

Indicator ADX (14)

22.22, 18.92, 29.73
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of AKER Akers Biosciences Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
16 Fri Apr 2021 2.47 2.40 to 3.04 -9.52% 5.73 times
15 Thu Apr 2021 2.73 2.60 to 2.87 2.25% 0.89 times
14 Wed Apr 2021 2.67 2.63 to 3.00 -9.8% 1.29 times
13 Tue Apr 2021 2.96 2.76 to 3.49 -15.19% 3.22 times
12 Mon Apr 2021 3.49 3.22 to 3.60 8.72% 1.39 times
09 Fri Apr 2021 3.21 3.20 to 3.36 -3.31% 0.19 times
08 Thu Apr 2021 3.32 3.29 to 3.42 -0.9% 0.23 times
07 Wed Apr 2021 3.35 3.21 to 3.42 3.4% 0.99 times
06 Tue Apr 2021 3.24 3.20 to 3.44 -2.7% 0.58 times
05 Mon Apr 2021 3.33 3.23 to 3.55 -1.19% 0.62 times
01 Thu Apr 2021 3.37 3.11 to 3.42 4.66% 0.61 times
31 Wed Mar 2021 3.22 3.02 to 3.27 5.23% 0.36 times

Videos related to: AKER NEWS why is Akers Biosciences Inc. price falling or rising

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Hindi Basics How To Trade In FnO Futures Options Stock Market

AKER NEWS why is Akers Biosciences Inc. price falling or rising

 

Back to top